TCL Archive Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase December 3, 2010
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges July 3, 2013
